Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Boll Soc Ital Biol Sper ; 66(6): 587-94, 1990 Jun.
Article in English | MEDLINE | ID: mdl-2175203

ABSTRACT

8-methoxycaffeine (8-MOC) is a caffeine derivative more potent than its parental compound in inducing chromosomal aberrations. 8-MOC has been postulated to produce chromosomal aberrations by DNA topoisomerase II inhibition. The effect of 8-MOC on nuclear DNA were studied by alkaline elution experiments and compared with those of Ellipticine and Adriamycin (ADR). Like Ellipticine and ADR, 8-MOC induced single strand breaks (SSBs), double strand breaks (DSBs), and DNA-protein cross-links (DPCs) in a bell-shaped manner with respect to drug concentration. As in the case of ADR and Ellipticine, 8-MOC induced equal SSB and DPC frequencies. These results could suggest that 8-MOC induces DNA breaks by interacting with DNA topoisomerase II or with a similar DNA metabolism enzyme.


Subject(s)
Caffeine/analogs & derivatives , Chromosome Aberrations , Cross-Linking Reagents/pharmacology , DNA Damage , Intercalating Agents/pharmacology , Leukemia L1210/pathology , Topoisomerase II Inhibitors , Animals , Caffeine/pharmacology , Doxorubicin/pharmacology , Ellipticines/pharmacology , Mice , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/ultrastructure
2.
Ann Ist Super Sanita ; 25(1): 41-50, 1989.
Article in English | MEDLINE | ID: mdl-2546474

ABSTRACT

The results presented here point to the difficulties that exist in connection with the identification of the molecular target of caffeine. Our data support the evidence that caffeine and caffeine derivatives cause DNA-protein cross-links (DPC) in whole mammalian cells or in isolated nuclei. These DPC have the same properties (saturability, reversibility and temperature-dependence) as those produced by an enzymatic inhibition. The experiments performed in reconstituted systems, in the presence of purified DNA topoisomerase II, do not support the original hypothesis that this enzyme might be a possible target for this class of drugs. We suggest the possibility that other DNA metabolism enzymes are involved in the biological effects of caffeine and caffeine derivatives. Further biochemical and molecular data are necessary to identify which of these enzymes is in fact affected.


Subject(s)
Caffeine/toxicity , DNA Damage , DNA, Single-Stranded/drug effects , Animals , Caffeine/analogs & derivatives , DNA Topoisomerases, Type II/metabolism , Humans , Leukemia L1210/enzymology , Leukemia L1210/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...